FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024276500> ?p ?o ?g. }

• W2024276500 endingPage "949" @default.
• W2024276500 startingPage "937" @default.
• W2024276500 abstract "Phosphorylase kinase (PhK), also known as adenosine triphosphate (ATP)-phosphorylase b phosphotransferase, integrates multiple calcium/calmodulin-dependent signalling pathways, including those involved in cell migration and cell proliferation, while coupling these pathways to glycogenolysis and ATP-dependent phosphorylation, thus ensuring continuing energy supply for these activities.Our laboratory recently reported correlation of elevated PhK activity with psoriatic activity. This study further evaluates the significance of drug-induced suppression of PhK activity on psoriatic activity.PhK activity was assayed in four groups, each with 10 patients: (i) active untreated psoriasis; (ii) resolving psoriasis treated by calcipotriol (Dovonex(R), Bristol Myers Squibb, Princeton, NJ, U.S.A. ), a vitamin D3 analogue and an indirect inhibitor of PhK; (iii) curcumin (diferuloylmethane), a selective PhK inhibitor; and (iv) 10 normal non-psoriatic subjects.PhK activity in units mg-1 protein was highest in active untreated psoriasis (1204 +/- 804.3; mean +/- SD), lower in the calcipotriol-treated group (550.7 +/- 192. 9), lower in curcumin-treated group (207.2 +/- 97.6), and lowest in normal skin (105.4 +/- 44.6). One-way analysis of variance performed on log-transformed PhK activity measure showed significant differences among the four groups, F3,36 = 48.79, P < 0.0001. Decreased PhK activity in curcumin-and calcipotriol-treated psoriasis was associated with corresponding decreases in keratinocyte transferrin receptor (TRR) expression, severity of parakeratosis and density of epidermal CD8+ T cells.Our results demonstrate that drug-induced suppression of PhK activity is associated with resolution of psoriatic activity as assessed by clinical, histological and immunohistochemical criteria, and support the hypothesis that effective antipsoriatic activity may be achieved through modulation of PhK activity." @default.
• W2024276500 created "2016-06-24" @default.
• W2024276500 creator A5002573985 @default.
• W2024276500 creator A5004128479 @default.
• W2024276500 creator A5088218177 @default.
• W2024276500 date "2000-11-01" @default.
• W2024276500 modified "2023-10-16" @default.
• W2024276500 title "Drug‐induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters" @default.
• W2024276500 cites W1549093505 @default.
• W2024276500 cites W1572756764 @default.
• W2024276500 cites W1605989699 @default.
• W2024276500 cites W1606972408 @default.
• W2024276500 cites W1725731812 @default.
• W2024276500 cites W1966178825 @default.
• W2024276500 cites W1966890774 @default.
• W2024276500 cites W1985766599 @default.
• W2024276500 cites W2000329401 @default.
• W2024276500 cites W2001642626 @default.
• W2024276500 cites W2002796914 @default.
• W2024276500 cites W2004152200 @default.
• W2024276500 cites W2005961064 @default.
• W2024276500 cites W2010696261 @default.
• W2024276500 cites W2010866516 @default.
• W2024276500 cites W2011816945 @default.
• W2024276500 cites W2012973228 @default.
• W2024276500 cites W2018275786 @default.
• W2024276500 cites W2023196077 @default.
• W2024276500 cites W2023954622 @default.
• W2024276500 cites W2026285718 @default.
• W2024276500 cites W2026779757 @default.
• W2024276500 cites W2027113030 @default.
• W2024276500 cites W2027605693 @default.
• W2024276500 cites W2031440278 @default.
• W2024276500 cites W2034961199 @default.
• W2024276500 cites W2035413616 @default.
• W2024276500 cites W2043232583 @default.
• W2024276500 cites W2045563801 @default.
• W2024276500 cites W2049059636 @default.
• W2024276500 cites W2050281512 @default.
• W2024276500 cites W2055035196 @default.
• W2024276500 cites W2062273494 @default.
• W2024276500 cites W2065442708 @default.
• W2024276500 cites W2067777571 @default.
• W2024276500 cites W2068868559 @default.
• W2024276500 cites W2069948046 @default.
• W2024276500 cites W2071972670 @default.
• W2024276500 cites W2080508536 @default.
• W2024276500 cites W2082721745 @default.
• W2024276500 cites W2083449096 @default.
• W2024276500 cites W2084077078 @default.
• W2024276500 cites W2084745814 @default.
• W2024276500 cites W2086046451 @default.
• W2024276500 cites W2087008857 @default.
• W2024276500 cites W2093065038 @default.
• W2024276500 cites W2097303911 @default.
• W2024276500 cites W2112900858 @default.
• W2024276500 cites W2143294211 @default.
• W2024276500 cites W2163504863 @default.
• W2024276500 cites W2164946653 @default.
• W2024276500 cites W2414679944 @default.
• W2024276500 cites W2869189 @default.
• W2024276500 cites W2913077122 @default.
• W2024276500 cites W4251839213 @default.
• W2024276500 cites W4256446759 @default.
• W2024276500 cites W4319308347 @default.
• W2024276500 cites W1995311643 @default.
• W2024276500 doi "https://doi.org/10.1046/j.1365-2133.2000.03767.x" @default.
• W2024276500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11069500" @default.
• W2024276500 hasPublicationYear "2000" @default.
• W2024276500 type Work @default.
• W2024276500 sameAs 2024276500 @default.
• W2024276500 citedByCount "157" @default.
• W2024276500 countsByYear W20242765002012 @default.
• W2024276500 countsByYear W20242765002013 @default.
• W2024276500 countsByYear W20242765002014 @default.
• W2024276500 countsByYear W20242765002015 @default.
• W2024276500 countsByYear W20242765002016 @default.
• W2024276500 countsByYear W20242765002017 @default.
• W2024276500 countsByYear W20242765002018 @default.
• W2024276500 countsByYear W20242765002019 @default.
• W2024276500 countsByYear W20242765002020 @default.
• W2024276500 countsByYear W20242765002021 @default.
• W2024276500 countsByYear W20242765002022 @default.
• W2024276500 countsByYear W20242765002023 @default.
• W2024276500 crossrefType "journal-article" @default.
• W2024276500 hasAuthorship W2024276500A5002573985 @default.
• W2024276500 hasAuthorship W2024276500A5004128479 @default.
• W2024276500 hasAuthorship W2024276500A5088218177 @default.
• W2024276500 hasConcept C126322002 @default.
• W2024276500 hasConcept C134018914 @default.
• W2024276500 hasConcept C195147555 @default.
• W2024276500 hasConcept C203014093 @default.
• W2024276500 hasConcept C204779464 @default.
• W2024276500 hasConcept C2776009542 @default.
• W2024276500 hasConcept C2777499176 @default.
• W2024276500 hasConcept C2780564577 @default.
• W2024276500 hasConcept C71924100 @default.
• W2024276500 hasConceptScore W2024276500C126322002 @default.

• next